<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PBYI
Puma Biotechnology
$
()


  • FDA allows Puma to proceed under IND with alisertib development for BC

    3/20/2024 - 08:37am
  • Puma Biotechnology says court denied AstraZeneca's motion for invalidity

    3/19/2024 - 22:17pm
  • Puma Biotechnology price target lowered by $1 at H.C. Wainwright, here's why

    3/1/2024 - 08:25am
  • Fly Intel: After-Hours Movers

    2/29/2024 - 18:22pm
  • Puma Biotechnology sees Fy24 revenue $214M-$225M, consensus $244.7M

    2/29/2024 - 16:19pm
  • Puma Biotechnology sees Q1 revenue $40.5M-$43M, one estimate 56.5M

    2/29/2024 - 16:18pm
  • Puma Biotechnology reports Q4 EPS 31c, consensus 30c

    2/29/2024 - 16:18pm
  • Puma inititates ALISCA-Lung1 Phase II trial of Alisertib in SCLC

    2/13/2024 - 08:51am
  • Biotech Alert: Searches spiking for these stocks today

    1/19/2024 - 11:24am
  • Biotech Alert: Searches spiking for these stocks today

    1/18/2024 - 11:32am
  • Puma Biotechnology announces design of alisertib trial

    12/11/2023 - 08:43am
  • Biotech Alert: Searches spiking for these stocks today

    11/15/2023 - 10:50am
  • Puma Biotechnology sees Q4 product revenue $56M-$59M

    11/2/2023 - 16:25pm
  • Puma Biotechnology reports Q3 EPS 17c, consensus 8c

    11/2/2023 - 16:24pm
  • Puma presents findings from Phase I/II study of alisertib, pembrolizumab

    10/15/2023 - 06:47am
dynamic_feed Breaking News